Teva Pharmaceuticals (Israel)

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Doron Lipson, Marzia Capelletti, Roman Yelensky et al. · Nature Medicine · 2012 · 860 citations · Full text

Tumor Biology, Radiation Oncology, Lung Cancer Biopsies +13

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor et al. · Annals of Neurology · 2007 · 423 citations · Full text

Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels

Leif Bjermer, Catherine Lemière, Jorge Máspero et al. · CHEST Journal · 2016 · 420 citations

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

Michel D. Ferrari, Hans‐Christoph Diener, Xiaoping Ning et al. · The Lancet · 2019 · 418 citations

Cluster Headache, Documented Failure, Clinical Trials +7

Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with Passaging

Svetlana Halfon, Natalie Abramov, Borislava Grinblat et al. · Stem Cells and Development · 2010 · 322 citations